Waldenström's macroglobulinemia differential diagnosis
Waldenström's macroglobulinemia Microchapters |
Differentiating Waldenström's macroglobulinemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Waldenström's macroglobulinemia differential diagnosis On the Web |
American Roentgen Ray Society Images of Waldenström's macroglobulinemia differential diagnosis |
FDA on Waldenström's macroglobulinemia differential diagnosis |
CDC on Waldenström's macroglobulinemia differential diagnosis |
Waldenström's macroglobulinemia differential diagnosis in the news |
Blogs on Waldenström's macroglobulinemia differential diagnosis |
Directions to Hospitals Treating Waldenström's macroglobulinemia |
Risk calculators and risk factors for Waldenström's macroglobulinemia differential diagnosis |
Waldenström's macroglobulinemia must be differentiated from other B cell lymphoid neoplasms including:
- Chronic lymphocytic leukemia/small lymphocytic lymphoma:
- Always express CD5, usually CD23 positive[1]
- B-cell prolymphocytic leukemia:
- Express bright surface IgM, CD20 and other B-cell antigens (CD19, CD22, CD79a, FMC7)[1]
- Follicular lymphoma:
- Multiple myeloma:
- Mantle cell lymphoma:
- Marginal zone lymphoma:
References=
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 Clinical manifestations, pathologic features, and diagnosis of lymphoplasmacytic lymphoma. UpToDate (2015)http://www.uptodate.com/contents/clinical-manifestations-pathologic-features-and-diagnosis-of-lymphoplasmacytic-lymphoma?source=see_link§ionName=PATHOGENESIS&anchor=H198194648#H198194648 Accessed on November 9, 2015
- ↑ 2.0 2.1 2.2 2.3 Sahin I, Leblebjian H, Treon SP, Ghobrial IM (2014). "Waldenström macroglobulinemia: from biology to treatment". Expert Rev Hematol. 7 (1): 157–68. doi:10.1586/17474086.2014.871494. PMID 24405328.